Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
50
LGND Quote, Financials, Valuation and Earnings
Last price:
$115.00
Seasonality move
:
9.17%
Day range:
$111.00 - $115.47
52-week range:
$67.53 - $129.90
Dividend yield:
0%
P/E ratio:
45.65x
P/S ratio:
13.58x
P/B ratio:
2.57x
Volume:
528.7K
Avg. volume:
139K
1-year change:
65.27%
Market cap:
$2.2B
Revenue:
$131.3M
EPS (TTM):
$2.51
Earnings Data
Next earnings date for LGND
Feb 27
2025
Most recent earnings per share
-$0.39
Missed by $1.74
(Nov 7/2024)
Consensus Estimate
$1.35
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LGND Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/27/2025 | Q4 | $39M | -- | -- | $1.18 | -- |
| 11/07/2024 | Q3 | $40.6M | $51.8M | -$0.39 | $1.35 | -$1.74 |
| 08/06/2024 | Q2 | $34.3M | $41.5M | -$2.88 | $1.06 | -$3.94 |
| 05/07/2024 | Q1 | $27.9M | $31M | $4.75 | $0.83 | $3.92 |
| 02/27/2024 | Q4 | $25.6M | $28.1M | $1.03 | $0.66 | $0.37 |
| 11/08/2023 | Q3 | -- | -- | -$0.59 | $0.62 | -$1.21 |
| 08/08/2023 | Q2 | -- | -- | $0.13 | $0.66 | -$0.53 |
| 05/04/2023 | Q1 | -- | -- | $2.33 | $0.89 | $1.44 |
| 02/22/2023 | Q4 | -- | -- | -$1.04 | $1.12 | -$2.16 |
| 11/07/2022 | Q3 | -- | -- | $0.02 | $0.43 | -$0.41 |
| 08/08/2022 | Q2 | -- | -- | -$0.05 | $0.43 | -$0.48 |
| 05/04/2022 | Q1 | -- | -- | -$0.91 | $0.66 | -$1.57 |
| 02/17/2022 | Q4 | -- | -- | -$0.30 | $1.37 | -$1.67 |
| 11/09/2021 | Q3 | -- | -- | $0.80 | $1.04 | -$0.24 |
| 07/29/2021 | Q2 | -- | -- | $1.79 | $1.36 | $0.43 |
| 05/03/2021 | Q1 | -- | -- | $1.05 | $1.13 | -$0.08 |
| 02/03/2021 | Q4 | -- | -- | $0.35 | $1.09 | -$0.74 |
| 10/30/2020 | Q3 | -- | -- | -$0.42 | $0.98 | -$1.40 |
| 08/03/2020 | Q2 | -- | -- | $1.32 | $0.76 | $0.56 |
| 05/06/2020 | Q1 | -- | -- | -$1.46 | $0.66 | -$2.12 |
| 02/06/2020 | Q4 | -- | -- | -$0.43 | $0.65 | -$1.08 |
| 11/05/2019 | Q3 | -- | -- | -$0.81 | $0.62 | -$1.43 |
| 07/30/2019 | Q2 | -- | -- | -$0.74 | $0.55 | -$1.29 |
| 05/02/2019 | Q1 | -- | -- | $31.32 | $15.45 | $15.87 |
| 02/07/2019 | Q4 | -- | -- | -$2.02 | $1.22 | -$3.24 |
| 11/08/2018 | Q3 | -- | -- | $2.80 | $1.03 | $1.77 |
| 08/06/2018 | Q2 | -- | -- | $2.99 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | $1.83 | -- | -- |
| 02/21/2018 | Q4 | -- | -- | -$0.33 | -- | -- |
| 11/09/2017 | Q3 | -- | -- | $0.36 | -- | -- |
| 08/07/2017 | Q2 | -- | -- | $0.26 | -- | -- |
| 05/09/2017 | Q1 | -- | -- | $0.22 | -- | -- |
| 02/23/2017 | Q4 | -- | -- | -$0.15 | -- | -- |
| 11/03/2016 | Q3 | -- | -- | $0.05 | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -$0.30 | -- | -- |
| 05/04/2016 | Q1 | -- | -- | $0.30 | -- | -- |
| 02/10/2016 | Q4 | -- | -- | $0.29 | -- | -- |
| 11/09/2015 | Q3 | -- | -- | $9.28 | -- | -- |
| 08/05/2015 | Q2 | -- | -- | $1.11 | -- | -- |
| 05/11/2015 | Q1 | -- | -- | $0.04 | -- | -- |
| 02/09/2015 | Q4 | -- | -- | $0.34 | -- | -- |
Ligand Pharmaceuticals Earnings Questions
-
How Much did Ligand Pharmaceuticals Generate in Revenue Last Quarter?
Ligand Pharmaceuticals reported $51.8M worth of top line sales in its most recent quarter.
-
Did Ligand Pharmaceuticals Beat Earnings Last Quarter?
Ligand Pharmaceuticals announced earnings per share of -$0.39 which represents a miss of analyst forecast a $1.35 per share.
-
Is Ligand Pharmaceuticals Profitable?
Ligand Pharmaceuticals reported $49.4M that represents $2.68 per share over the last quarter.
-
What is the Analyst Consensus for Ligand Pharmaceuticals EPS Next Year?
Ligand Pharmaceuticals's earnings are forecast to grow from $2.94 per share to $5.35 per share next year representing an increase of 92.04%.
-
When is Ligand Pharmaceuticals's Earnings Date?
Ligand Pharmaceuticals's next earnings date is February 27, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
